$4.16
-0.1-2.35%
At close: -
$4.16
0.000.00%
After Hours: Dec 20, 4:06 PM EDT
Relay Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Relay Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.63 | $-0.77 | 18.2 % |
Jun 2024 | 2024-08-06 | $-0.69 | $-0.73 | 5.48 % |
Mar 2024 | 2024-05-02 | $-0.62 | $-0.71 | 12.7 % |
Dec 2023 | 2024-02-22 | $-0.67 | $-0.73 | 8.22 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0 | $80.00K | -100.0 % |
Mar 2024 | 2024-05-02 | $10.01M | $90.00K | 11018.9 % |
Dec 2023 | 2024-02-22 | $0 | $130.00K | -100.0 % |
Jun 2023 | 2023-08-08 | $119.00K | $750.00K | -84.1 % |
Relay Therapeutics (RLAY) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.63, which beat the estimate of $-0.77.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.